Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
10/2005
10/19/2005EP1200095B1 Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances
10/19/2005EP1102752B1 Succinoylamino lactams as inhibitors of a beta protein production
10/19/2005CN1684682A Small organic molecules that increase the activity of gelatinase A in ocular cells
10/19/2005CN1683343A Novel method of synthesising 1, 3, 4, 5-tetrahydro-2H-3-benzazepin-2-one derivatives and use thereof in the synthesis of ivabradine and the salts thereof for addition to a pharmaceutically acceptable aci
10/19/2005CN1683342A New process for the synthesis of 1, 3-dihydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/19/2005CN1683341A New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005094835A1 M3 muscarinic acetylcholine receptor antagonists
10/13/2005WO2005094834A1 Muscarinic acetylcholine receptor antagonists
10/13/2005US20050228178 Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds. and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/13/2005US20050228177 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/13/2005US20050227962 Process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/13/2005US20050226776 Use of microfabricated devices
10/13/2005DE10392134T5 Azaphenylalaninderivate Azaphenylalaninderivate
10/12/2005CN1680331A Method for producing epsilon-caprolactam
10/12/2005CN1680036A Method for producing epsilon-carpolactam and method for reactivating catalyst for producing epsilon-carpolactam
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953788 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
10/11/2005US6953787 5HT2C receptor modulators
10/06/2005WO2005092862A1 Process for preparing oxcarbazepine
10/06/2005WO2005092290A1 Disintegrating tablets comprising licarbazepine
10/06/2005WO2005066133A3 NOVEL PROCESS FOR PREPARATION OF 10-OXO-10, 11-DIHYDRO-5H-DIBENZ [b,f]AZEPINE-5-CARBOXAMIDE (OXCARBAZEPINE) VIA INTERMEDIATE, 10-METHOXY-5H-DIBENZ[b,f] AZEPINE-5-CARBONYLCHLORIDE
10/06/2005US20050222407 Method for the preparation of ethylenically unsaturated compounds with lactam-blocked isocyanate groups
10/06/2005US20050222124 Benzenesulfonamide derivatives as antipsychotic agents
10/06/2005CA2558307A1 Disintegrating tablets comprising licarbazepine
10/05/2005EP1582515A1 Method for producing epsilon-caprolactam
10/05/2005EP1278727B1 Method for producing cyclic lactams
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/04/2005US6951872 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
10/04/2005US6951854 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
09/2005
09/29/2005WO2005042697A3 Compounds, compositions and methods
09/29/2005US20050215637 Tuberculosis treatment
09/29/2005US20050215541 Alzheimer's disease; benzodiazapines
09/28/2005EP1578748A1 Tetrahydro-4h-pyrido [1, 2-a] pyrimidines and related compounds useful as hiv integrase inhibitors
09/28/2005EP1578198A1 Pesticidal dibenzo(hetero)azepine derivatives
09/28/2005EP1307430B1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
09/28/2005CN1674909A Use of carboxamides for the treatment of tinnitus
09/28/2005CN1674885A Methods for treatment and prevention of gastrointestinal conditions
09/27/2005US6949583 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
09/27/2005US6949291 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers
09/22/2005WO2005087746A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
09/22/2005WO2004060376A8 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
09/22/2005US20050209215 Reacting 2-(11H-dibenz[b,e]azepin-6-ylmethyl)-1H-isoindole-1,3(2H)-dione with a metal hydride or a metal hydride complex (sodium borohydride); antiallergic and antihistamine; hydrazine free
09/21/2005EP1577288A1 Selective estrogen receptor modulators
09/21/2005CN1671663A Pleuromutilin
09/21/2005CN1670017A Method for separating Beckmann rearrangement reaction products from ion liquid
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2151604C Application of riluzole in the treatment of neurological lesions associated with traumas
09/15/2005WO2005085183A1 Method of preparing benzazepines and derivatives thereof
09/15/2005WO2005053702A3 Anti-inflammatory agents
09/15/2005US20050203297 Process for the preparation of carboxamide compounds
09/15/2005US20050203294 Process for the preparation of benazepril hydrochloride
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/15/2005US20050203080 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
09/15/2005CA2557731A1 Method of preparing benzazepines and derivatives thereof
09/14/2005EP1572215A1 Benzo[d]azepine derivatives for the treatment of neurological disorders
09/14/2005EP1572210A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
09/14/2005CN1668721A Immunoadhesin comprising a glycoprotein VI domain
09/13/2005US6943196 NF-κB inhibitor comprising phenylmethyl benzoquinone as the active ingredient
09/13/2005US6943179 Biurethane derivatives
09/13/2005US6943169 Quinolinone derivatives and uses thereof
09/09/2005WO2005082859A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
09/09/2005WO2004093796A3 Lactam derivatives and methods of their use
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/07/2005CN1665801A Anti tubercular drug: compositions and methods
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
08/2005
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
08/30/2005US6936602 Benzazepine derivatives, process for the preparation of the same and uses thereof
08/25/2005WO2005077921A1 Guanidine compound and asymmetric reaction using the same
08/25/2005WO2005077908A1 Guanidine compound and asymmetric reaction using the same
08/25/2005WO2005077907A1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases
08/25/2005US20050187210 Method for treating severe heart failure and medicament therefor
08/25/2005DE102004006325A1 New benzazepine derivatives useful for treating or preventing dyslipidemia, arteriosclerosis, restenosis and ischemia
08/25/2005CA2554996A1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases
08/24/2005EP1565192A2 Method and compositions for temporarily incapaciting subjets
08/24/2005EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
08/24/2005EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1658881A Anti-inflammatory compositions and methods of use
08/18/2005WO2005030794A3 Hemiasterlin derivatives and uses thereof
08/18/2005US20050182254 Method for producing epsilon-caprolactam and method for reactivating catalyst for production of epsilon-caprolactam
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182046 Alzheimer's disease; 3-(S)-(N'-(3,5-difluorophenylacetyl)-L-alaninyl)amino-1-benzyl- epsilon -caprolactam; 4-(N'-(3,5-Difluorophenylacetyl)-L-alaninyl)amino-1-(pyrid-4-yl)-71,2,3,4-tetrahydroisoquinolin-3-one
08/18/2005US20050182040 Benzamide derivatives
08/17/2005EP1564719A2 Sound emission device and siren, particularly for alarm systems for motor vehicles, motorcycles, enclosed spaces and the like
08/17/2005EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
08/16/2005US6930183 a lubricant additive effective for imparting antioxidant properties to a lubricating oil, fuel composition, or rubber formulation
08/11/2005WO2005073196A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
08/11/2005WO2004110983A8 New benzamides as pparϒ modulators
08/11/2005US20050176954 from mixtures comprising caprolactam, water, light components including unsaturated lactams and heavy components, by vacuum distillation, then hydrogenating the unsaturated lactams
08/11/2005US20050176759 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disorders
08/10/2005CN1652843A Methods for the treatment of respiratory diseases and conditions using a selective iNOS inhibitor
08/10/2005CN1213993C Method for separating imine from mixture containing amine and imine
08/04/2005WO2005070887A1 Bronchorelaxing compounds
08/04/2005WO2005070877A1 Diamino alcohols and their use as renin inhibitors
08/04/2005WO2005019179A3 Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 88